Rhenman & Partners Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-40,000	Closed	-$2.52M	–	98
2020 Q1	$2.52M	Hold	40,000	–	–	0.35%	71
2019 Q4	$4.96M	Sell	40,000 -7,600	-16%	-$942K	0.54%	65
2019 Q3	$3.16M	Buy	47,600 +10,000	+27%	+$664K	0.4%	66
2019 Q2	$2.99M	Buy	+37,600	New	+$2.99M	0.33%	67
2018 Q1	–	Sell	-38,500	Closed	-$2.25M	–	100
2017 Q4	$2.25M	Sell	38,500 -1,500	-4%	-$87.6K	0.3%	71
2017 Q3	$2.32M	Buy	40,000 +36,992	+1,230%	+$2.15M	0.3%	74
2017 Q2	$364K	Sell	3,008 -26,992	-90%	-$3.27M	0.05%	96
2017 Q1	$3.39M	Buy	30,000 +10,000	+50%	+$1.13M	0.54%	65
2016 Q4	$2.17M	Buy	20,000 +10,000	+100%	+$1.09M	0.42%	70
2016 Q3	$1.65M	Buy	+10,000	New	+$1.65M	0.26%	84
2016 Q1	–	Sell	-26,000	Closed	-$3.88M	–	96
2015 Q4	$3.88M	Sell	26,000 -6,000	-19%	-$896K	0.59%	59
2015 Q3	$5.31M	Buy	32,000 +8,000	+33%	+$1.33M	0.85%	47
2015 Q2	$5.79M	Buy	24,000 +1,000	+4%	+$241K	0.7%	45
2015 Q1	$6.49M	Buy	23,000 +1,000	+5%	+$282K	1.09%	33
2014 Q4	$3.43M	Buy	22,000 +3,400	+18%	+$530K	0.99%	35
2014 Q3	$4.4M	Buy	+18,600	New	+$4.4M	1.29%	25